0002

Il Dong Holdings Co., Ltd. (000230)

Market Closed
12 Dec, 06:30
KRX SM KRX SM
15,810. 00
+10
+0.06%
145.89B Market Cap
- P/E Ratio
400% Div Yield
1,462,206 Volume
- Eps
15,800
Previous Close
Day Range
15,010 17,100
Year Range
5,750 17,170
Want to track 000230 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 53 days

Summary

000230 closed Friday higher at ₩15,810, an increase of 0.06% from Thursday's close, completing a monthly increase of 25.48% or ₩3,210. Over the past 12 months, 000230 stock gained 86%.
000230 is not paying dividends to its shareholders.
The last earnings report, released on Oct 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 2,133.75%, based on the last three reports. The next scheduled earnings report is due on Feb 05, 2026.
Il Dong Holdings Co., Ltd. has completed 2 stock splits, with the recent split occurring on Mar 05, 2020.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).

000230 Chart

Similar

H.S. Industries Co. Ltd.
3,775
+0.67%
Motrex Co. Ltd.
8,650
+1.65%
JTC Inc.
3,850
-0.52%
Chinyang Holdings Corp.
3,345
+1.52%
Pang Rim Co., Ltd.
5,890
0%

Il Dong Holdings Co., Ltd. (000230) FAQ

What is the stock price today?

The current price is ₩15,810.00.

On which exchange is it traded?

Il Dong Holdings Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 000230.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 400%.

What is its market cap?

As of today, the market cap is 145.89B.

When is the next earnings date?

The next earnings report will release on Feb 05, 2026.

Has Il Dong Holdings Co., Ltd. ever had a stock split?

Il Dong Holdings Co., Ltd. had 2 splits and the recent split was on Mar 05, 2020.

Il Dong Holdings Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Dae-Chang Park CEO
KRX SM Exchange
KR7000230003 ISIN
KR Country
72 Employees
- Last Dividend
5 Mar 2020 Last Split
- IPO Date

Overview

Ildong Holdings Co., Ltd., originally known as Ildong Pharmaceutical Co., Ltd. before its name change in August 2016, stands as a significant player in the pharmaceutical industry both within South Korea and on an international level. Founded in 1941 and headquartered in Seoul, South Korea, the company specializes in the development, manufacture, and supply of pharmaceutical products. Over the years, Ildong Holdings has diversified its offerings to include new drug development focused on combating resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing. Furthermore, the company extends its expertise to the research and production of health foods and ingredients, demonstrating its commitment to enhancing healthcare through innovation.

Products and Services

  • New Drug Development: Ildong Holdings is at the forefront of innovation, developing new drugs to address critical health issues like resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing. Their research and development efforts aim to provide groundbreaking treatments to improve patient outcomes globally.
  • Raw Vitamins, Probiotics, and Antimicrobials: The company manufactures essential health-enhancing products including raw vitamins to support overall health, probiotics for gut health, and antimicrobials to fight infections.
  • Biovita: A lactobacillus product developed by Ildong Holdings, Biovita promotes digestive health by maintaining gut flora balance, showcasing the company's dedication to probiotic solutions.
  • Aronamin: This multivitamin product is designed to meet daily health requirements by supplying essential nutrients, reflecting the company’s focus on preventative healthcare.
  • Health Foods and Ingredients Research and Manufacture: Ildong Holdings invests in the research and manufacture of health foods and ingredients, endorsing their vision for a healthier future through nutrition science.
  • Hyaluronic Acid for Medical and Cosmetic Use: The company provides high-quality hyaluronic acid, a key ingredient used in drugs, medical devices, and cosmetics, highlighting its versatility and importance in various industries.
  • Medical Devices and Healthcare Products Distribution: Through online platforms, Ildong Holdings distributes medical devices, quasi-drugs, health supplements, food products, beverages, cosmetics, sanitary ware, and other healthcare products, ensuring a wide reach to consumers and healthcare facilities.
  • Original and Generic Prescription Drugs Manufacturing: Engaging in the manufacturing of both original and generic prescription drugs positions Ildong Holdings as a crucial entity in the pharmaceutical supply chain, aimed at providing accessible medication options.
  • Pharmaceutical SI Consulting and Solutions: The company offers pharmaceutical SI consulting, system development and deployment, RFID and barcode systems, and other solutions, demonstrating its capability to innovate not just in products but also in services that enhance the efficiency of the pharmaceutical and healthcare industries.
  • Advertising Business: Ildong Holdings also engages in advertising business activities, showcasing its diverse interests and its ability to promote healthcare solutions effectively to the market.

Contact Information

Address: 2, Baumoe-ro 27-gil, Seoul, South Korea, 06752
Phone: 82 2 526 3114